MedTrace Logo

Transesophageal Echocardiology Measured Left Ventricular End Diastolic Area As Guide for Fluid Therapy in Major Oncosurgeries

NCT03853031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-01-22

No results posted yet for this study

Summary

Intraoperative fluid management is pivotal to successful outcome of major oncosurgeries . Adequate volume replacement to achieve optimal cardiac performance is critical to prevent any deleterious consequences of under resuscitation or fluid overload . Traditionally CVP monitoring has been tool to guide intraoperative fluid therapy and has poor reliability as indicator of volume status . Transesophageal Echocardiography measured LVEDA is more reliable and sensitive measure of left ventricular volume to guide intraoperative fluid therapy . Investigators plan the study comparing total fluid requirement and postoperative outcomes in two groups of patients receiving central venous pressure (CVP) guided Conventional Fluid Therapy (CFT) and Left ventricular end diastolic area( LVEDA) guided fluids for major oncosurgeries.

Conditions

  • Fluid Therapy DURING SURGERY

Interventions

PROCEDURE

LVEDA cm2 guided intraoperative fluid in TEE /Study Group

Placement of Transoesophageal echocardiography probe in TEE group to measure Left ventricular end diastolic area cm2

PROCEDURE

CVP guided intraoperative fluid in CVP / Control group

Ultrasound guided Internal Jugular Vein catheter placement in CVP group to measure CVP value cms H2O .

Sponsors & Collaborators

  • Rajiv Gandhi Cancer Institute & Research Center, India

    lead OTHER

Principal Investigators

  • Anita Kulkarni, MD · Rajiv Gandhi Cancer Institute & Research Centre , India

  • Anita Kulkarni, M.D. · Rajiv Gandhi Cancer Institute & Research Centre , India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-06
Primary Completion
2019-04-30
Completion
2019-05-10

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853031 on ClinicalTrials.gov